Electromedical Technologies（EMED）株式概要バイオエレクトロニクスの製造・販売会社であるエレクトロメディカル・テクノロジーズ社は、米国で疼痛管理用の医療機器を提供している。 詳細EMED ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績0/6財務の健全性0/6配当金0/6リスク分析意味のある時価総額がありません ( $746K )最新の財務報告は1年以上前のものである US市場と比較して、過去 3 か月間の株価の変動が非常に大きい過去1年間で株主の希薄化が進んだ すべてのリスクチェックを見るEMED Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$0.0001571.2% 割安 内在価値ディスカウントEst. Revenue$PastFuture-11m1m2016201920222025202620282031Revenue US$922.0kEarnings US$122.3kAdvancedSet Fair ValueView all narrativesElectromedical Technologies, Inc. 競合他社STRATA Skin SciencesSymbol: OTCPK:SSKNMarket cap: US$897.4kLogicMarkSymbol: OTCPK:LGMKMarket cap: US$477.8kEscalon MedicalSymbol: OTCPK:ESMCMarket cap: US$1.3mENvue MedicalSymbol: NasdaqCM:FEEDMarket cap: US$1.4m価格と性能株価の高値、安値、推移の概要Electromedical Technologies過去の株価現在の株価US$0.0001552週高値US$0.000252週安値US$0.000001ベータ01ヶ月の変化3.45%3ヶ月変化-25.00%1年変化50.00%3年間の変化-95.79%5年間の変化-99.76%IPOからの変化-99.90%最新ニュースお知らせ • Jul 14Electromedical Technologies Files Form 15Electromedical Technologies, Inc. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its common under the Securities Exchange Act of 1934, as amended.お知らせ • Apr 01Electromedical Technologies, Inc. announced delayed annual 10-K filingOn 03/31/2025, Electromedical Technologies, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Nov 15Electromedical Technologies, Inc. announced delayed 10-Q filingOn 11/14/2024, Electromedical Technologies, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • May 17Electromedical Technologies, Inc. announced delayed 10-Q filingOn 05/15/2024, Electromedical Technologies, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Apr 04Electromedical Technologies, Inc. announced delayed annual 10-K filingOn 04/03/2024, Electromedical Technologies, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Nov 17Electromedical Technologies, Inc. announced delayed 10-Q filingOn 11/15/2023, Electromedical Technologies, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.最新情報をもっと見るRecent updatesお知らせ • Jul 14Electromedical Technologies Files Form 15Electromedical Technologies, Inc. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its common under the Securities Exchange Act of 1934, as amended.お知らせ • Apr 01Electromedical Technologies, Inc. announced delayed annual 10-K filingOn 03/31/2025, Electromedical Technologies, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Nov 15Electromedical Technologies, Inc. announced delayed 10-Q filingOn 11/14/2024, Electromedical Technologies, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • May 17Electromedical Technologies, Inc. announced delayed 10-Q filingOn 05/15/2024, Electromedical Technologies, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Apr 04Electromedical Technologies, Inc. announced delayed annual 10-K filingOn 04/03/2024, Electromedical Technologies, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Nov 17Electromedical Technologies, Inc. announced delayed 10-Q filingOn 11/15/2023, Electromedical Technologies, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jul 06Electromedical Technologies, Inc. Announces the Resignation of Robert L. Hymers as an Independent DirectorElectromedical Technologies, Inc. announced that Robert L. Hymers, III resigned as an independent director of the Company, effective July 1, 2023.お知らせ • Feb 03Electromedical Technologies, Inc. Appoints Robert L. Hymers, III as Independent Director and Member of the Compensation CommitteeElectromedical Technologies, Inc. announced that on February 1, 2023, effective January 1, 2023, the Company appointed Robert L. Hymers, III, age 39, as an independent director and member of the compensation committee of the Company for a term of six months.お知らせ • Dec 26Electromedical Technologies, Inc. Announces Board AppointmentsOn December 20, 2022, Electromedical Technologies, Inc. appointed Petar Gajic and Robert L. Hymers, III to the board of directors by written consent of the shareholder beneficially owning 60.04% of the votes eligible to be cast according to Sections 2.11 and 2.12(b) of the Company's By-Laws.お知らせ • Dec 22Electromedical Technologies, Inc. Announces Resignation of Lee Benson as an Independent DirectorOn December 12, 2022, Lee Benson resigned as an independent director of the Company. There was a disagreement with the Company on its compensation policy disclosable under Item 5.02(a).お知らせ • Nov 01Electromedical Technologies, Inc. Introduces the Wellnesspro Infinity™Electromedical Technologies, Inc. introduced its new next-generation device, the WellnessPro Infinity™. The NEW WellnessPro Infinity™ device features: One compact device that encompasses ALL electrotherapy modalities. Can produce any frequency, any wave form (typical or atypical), any level of modulation; Designed to support: TENS, Microcurrent, IF, EMS, PEMF, CES, VNS, PNS, COLD Laser, POD Synchronization, IDNA™, Deep Pluse™, Cloud access and much more. Unprecedented accuracy. Easiest to use electrotherapy device on the market. New Doctor-Patient Portal for updates and personalized treatments.お知らせ • Jun 14Electromedical Technologies, Inc. Appoints Lee Benson as an Independent DirectorOn June 7, 2022, Electromedical Technologies, Inc. appointed Lee Benson, age 61, as an independent director of the Company. Mr. Benson began his career as the first employee in a small company providing specialty electroplating services to repair aircraft components. Mr. Benson purchased the company 1993. He then went on to found Able Engineering & Component Services in 1995 and Able Aerospace in 1999, subsequently expanding from 3 to 500+ employees and driving 15 straight years of 20% compounded average annual growth. After he secured the sale, Mr. Benson founded Execute to Win, LLC to help other businesses achieve maximum success and profit from his experience and expertise. ETW offers consultancy services to help businesses develop and implement effective communication strategies affecting decision making and approaches to work.お知らせ • Feb 17Electromed, Inc., Appoints Christopher Holland as Chief Commercial OfficerElectromed, Inc. announced the appointment of Christopher Holland as Chief Commercial Officer. Mr. Holland, an accomplished sales and marketing veteran, brings 30 years of experience in driving commercial growth in the Medical Technology market to Electromed. Prior to joining Electromed, Holland was the Vice President of Commercialization at Prosomnus Sleep Technologies, Inc.お知らせ • Jun 11Electromedical Technologies Flagship Device to Be Introduced At National Chiropractic ExpoElectromedical Technologies, Inc. announced that Director Kathy Strand R.N. will be hosting a booth and featuring the EMED flagship device at the upcoming Parker Seminars semi-annual national expo for chiropractors and chiropractic assistants In Orlando, Florida from June 11-13, 2021, including including the FDA cleared WellnessPro Plus.お知らせ • Dec 10Electromedical Technologies, Inc. Announces Its New Strategic Partnership with WireBuzz, LLCElectromedical Technologies, Inc. announced its new strategic partnership with WireBuzz, LLC. The company elected to work with WireBuzz based upon its renowned reputation for content production, advanced marketing, and specifically, its impressive online customer conversion capabilities. In its first stage, WireBuzz is revamping the Company website to emulate the style and success of sites for WireBuzz Fortune 500 clients, and others. Future steps include the production of new marketing tools including video content for use by Electromedical Technologies’ distributors and influencers. WireBuzz produces more than 3,000 videos each year, which are extremely powerful and effective visual sales resources. The use of online content marketing is one of the most successful sales methods in the current COVID-19 environment and is expected to be a major driver of product sales, going forward.お知らせ • Jul 24Electromedical Technologies, Inc. announced that it expects to receive $1 million in fundingElectromedical Technologies, Inc. (OTCPK:ELCQ) announced an investment agreement for an aggregate gross proceeds of $1 million on July 23, 2020. The company will issue common shares in the transaction. The company will receive funding in three separate tranches.株主還元EMEDUS Medical EquipmentUS 市場7D-25.0%-3.4%2.1%1Y50.0%-21.0%30.6%株主還元を見る業界別リターン: EMED過去 1 年間で-21 % の収益を上げたUS Medical Equipment業界を上回りました。リターン対市場: EMED過去 1 年間で30.6 % の収益を上げたUS市場を上回りました。価格変動Is EMED's price volatile compared to industry and market?EMED volatilityEMED Average Weekly Movement82.8%Medical Equipment Industry Average Movement8.5%Market Average Movement7.2%10% most volatile stocks in US Market16.1%10% least volatile stocks in US Market3.2%安定した株価: EMEDの株価は、 US市場と比較して過去 3 か月間で変動しています。時間の経過による変動: EMEDの weekly volatility ( 83% ) は過去 1 年間安定していますが、依然としてUSの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト2002n/aMatthew Wolfsonelectromedtech.comバイオエレクトロニクスの製造・販売会社であるエレクトロメディカル・テクノロジーズ社は、米国で疼痛管理用の医療機器を提供している。同社は、消費者や医療専門家が慢性および急性の痛みを和らげるために使用するバイオエレクトロニクスセラピー処方機器、ウェルネスプロ・プラスを提供している。また、疼痛管理用のコンパクトな臨床グレードのウェアラブル機器であるウェルネスプロPODや、循環と組織治癒を改善し、炎症と痛みを軽減するために標的周波数刺激を与えるために使用される干渉性コールドレーザーであるウェルネスIONペンも開発している。同社はカイロプラクター、理学療法士、疼痛管理の医師や臨床医、自然医学の医師、スポーツ医学の医師、アスレティックトレーナーにサービスを提供している。エレクトロメディカル・テクノロジーズ社は2002年に設立され、アリゾナ州スコッツデールに本社を置いている。もっと見るElectromedical Technologies, Inc. 基礎のまとめElectromedical Technologies の収益と売上を時価総額と比較するとどうか。EMED 基礎統計学時価総額US$746.46k収益（TTM）-US$1.68m売上高(TTM)US$922.01k0.0xP/Sレシオ0.0xPER（株価収益率EMED は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計EMED 損益計算書（TTM）収益US$922.01k売上原価US$229.78k売上総利益US$692.23kその他の費用US$2.37m収益-US$1.68m直近の収益報告Sep 30, 2024次回決算日該当なし一株当たり利益（EPS）0グロス・マージン0.00%純利益率0.00%有利子負債／自己資本比率0.0%EMED の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/07 07:56終値2026/05/07 00:00収益2024/09/30年間収益2023/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Electromedical Technologies, Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jul 14Electromedical Technologies Files Form 15Electromedical Technologies, Inc. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its common under the Securities Exchange Act of 1934, as amended.
お知らせ • Apr 01Electromedical Technologies, Inc. announced delayed annual 10-K filingOn 03/31/2025, Electromedical Technologies, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Nov 15Electromedical Technologies, Inc. announced delayed 10-Q filingOn 11/14/2024, Electromedical Technologies, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • May 17Electromedical Technologies, Inc. announced delayed 10-Q filingOn 05/15/2024, Electromedical Technologies, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Apr 04Electromedical Technologies, Inc. announced delayed annual 10-K filingOn 04/03/2024, Electromedical Technologies, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Nov 17Electromedical Technologies, Inc. announced delayed 10-Q filingOn 11/15/2023, Electromedical Technologies, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jul 14Electromedical Technologies Files Form 15Electromedical Technologies, Inc. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its common under the Securities Exchange Act of 1934, as amended.
お知らせ • Apr 01Electromedical Technologies, Inc. announced delayed annual 10-K filingOn 03/31/2025, Electromedical Technologies, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Nov 15Electromedical Technologies, Inc. announced delayed 10-Q filingOn 11/14/2024, Electromedical Technologies, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • May 17Electromedical Technologies, Inc. announced delayed 10-Q filingOn 05/15/2024, Electromedical Technologies, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Apr 04Electromedical Technologies, Inc. announced delayed annual 10-K filingOn 04/03/2024, Electromedical Technologies, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Nov 17Electromedical Technologies, Inc. announced delayed 10-Q filingOn 11/15/2023, Electromedical Technologies, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jul 06Electromedical Technologies, Inc. Announces the Resignation of Robert L. Hymers as an Independent DirectorElectromedical Technologies, Inc. announced that Robert L. Hymers, III resigned as an independent director of the Company, effective July 1, 2023.
お知らせ • Feb 03Electromedical Technologies, Inc. Appoints Robert L. Hymers, III as Independent Director and Member of the Compensation CommitteeElectromedical Technologies, Inc. announced that on February 1, 2023, effective January 1, 2023, the Company appointed Robert L. Hymers, III, age 39, as an independent director and member of the compensation committee of the Company for a term of six months.
お知らせ • Dec 26Electromedical Technologies, Inc. Announces Board AppointmentsOn December 20, 2022, Electromedical Technologies, Inc. appointed Petar Gajic and Robert L. Hymers, III to the board of directors by written consent of the shareholder beneficially owning 60.04% of the votes eligible to be cast according to Sections 2.11 and 2.12(b) of the Company's By-Laws.
お知らせ • Dec 22Electromedical Technologies, Inc. Announces Resignation of Lee Benson as an Independent DirectorOn December 12, 2022, Lee Benson resigned as an independent director of the Company. There was a disagreement with the Company on its compensation policy disclosable under Item 5.02(a).
お知らせ • Nov 01Electromedical Technologies, Inc. Introduces the Wellnesspro Infinity™Electromedical Technologies, Inc. introduced its new next-generation device, the WellnessPro Infinity™. The NEW WellnessPro Infinity™ device features: One compact device that encompasses ALL electrotherapy modalities. Can produce any frequency, any wave form (typical or atypical), any level of modulation; Designed to support: TENS, Microcurrent, IF, EMS, PEMF, CES, VNS, PNS, COLD Laser, POD Synchronization, IDNA™, Deep Pluse™, Cloud access and much more. Unprecedented accuracy. Easiest to use electrotherapy device on the market. New Doctor-Patient Portal for updates and personalized treatments.
お知らせ • Jun 14Electromedical Technologies, Inc. Appoints Lee Benson as an Independent DirectorOn June 7, 2022, Electromedical Technologies, Inc. appointed Lee Benson, age 61, as an independent director of the Company. Mr. Benson began his career as the first employee in a small company providing specialty electroplating services to repair aircraft components. Mr. Benson purchased the company 1993. He then went on to found Able Engineering & Component Services in 1995 and Able Aerospace in 1999, subsequently expanding from 3 to 500+ employees and driving 15 straight years of 20% compounded average annual growth. After he secured the sale, Mr. Benson founded Execute to Win, LLC to help other businesses achieve maximum success and profit from his experience and expertise. ETW offers consultancy services to help businesses develop and implement effective communication strategies affecting decision making and approaches to work.
お知らせ • Feb 17Electromed, Inc., Appoints Christopher Holland as Chief Commercial OfficerElectromed, Inc. announced the appointment of Christopher Holland as Chief Commercial Officer. Mr. Holland, an accomplished sales and marketing veteran, brings 30 years of experience in driving commercial growth in the Medical Technology market to Electromed. Prior to joining Electromed, Holland was the Vice President of Commercialization at Prosomnus Sleep Technologies, Inc.
お知らせ • Jun 11Electromedical Technologies Flagship Device to Be Introduced At National Chiropractic ExpoElectromedical Technologies, Inc. announced that Director Kathy Strand R.N. will be hosting a booth and featuring the EMED flagship device at the upcoming Parker Seminars semi-annual national expo for chiropractors and chiropractic assistants In Orlando, Florida from June 11-13, 2021, including including the FDA cleared WellnessPro Plus.
お知らせ • Dec 10Electromedical Technologies, Inc. Announces Its New Strategic Partnership with WireBuzz, LLCElectromedical Technologies, Inc. announced its new strategic partnership with WireBuzz, LLC. The company elected to work with WireBuzz based upon its renowned reputation for content production, advanced marketing, and specifically, its impressive online customer conversion capabilities. In its first stage, WireBuzz is revamping the Company website to emulate the style and success of sites for WireBuzz Fortune 500 clients, and others. Future steps include the production of new marketing tools including video content for use by Electromedical Technologies’ distributors and influencers. WireBuzz produces more than 3,000 videos each year, which are extremely powerful and effective visual sales resources. The use of online content marketing is one of the most successful sales methods in the current COVID-19 environment and is expected to be a major driver of product sales, going forward.
お知らせ • Jul 24Electromedical Technologies, Inc. announced that it expects to receive $1 million in fundingElectromedical Technologies, Inc. (OTCPK:ELCQ) announced an investment agreement for an aggregate gross proceeds of $1 million on July 23, 2020. The company will issue common shares in the transaction. The company will receive funding in three separate tranches.
